ERBB2 and neoplasm: No differences were observed in age, menopausal status, chemotherapy cycles, histological type, tumor size, clinical nodal status, histological grade, ER, PR, HER2, Ki67, or molecular subtypes between the high-PNI and low-PNI groups.